Pharmaceuticals news FT.com

GSK is emerging from its long convalescence

Drugmaker pins hopes on launch of new medicines but key point is to avoid re-traumatising investors

Feb 9, 2025 - 22:26
 0
GSK is emerging from its long convalescence
Drugmaker pins hopes on launch of new medicines but key point is to avoid re-traumatising investors
Read More

Tags:

Previous Article

The inside story of Britain’s failure to clinch £450mn AstraZeneca deal

Next Article

Eli Lilly expects to beat profit forecasts on obesity drug demand

Related Posts

‘Road map’ outlining how cancers spread offers hope for new treatments

‘Road map’ outlining how cancers spread offers hope for...

Feb 14, 2025  0

Psychiatric drug research held back by ‘stigma’, says top UK scientist

Psychiatric drug research held back by ‘stigma’, says t...

Feb 28, 2025  0

The inside story of Britain’s failure to clinch £450mn AstraZeneca deal

The inside story of Britain’s failure to clinch £450mn ...

Feb 9, 2025  0